EA200400461A1 - Применение экстрактов из растений семейства cimicifuga в качестве медикамента для лечения нарушений мочеполового тракта, связанных с половыми гормонами - Google Patents

Применение экстрактов из растений семейства cimicifuga в качестве медикамента для лечения нарушений мочеполового тракта, связанных с половыми гормонами

Info

Publication number
EA200400461A1
EA200400461A1 EA200400461A EA200400461A EA200400461A1 EA 200400461 A1 EA200400461 A1 EA 200400461A1 EA 200400461 A EA200400461 A EA 200400461A EA 200400461 A EA200400461 A EA 200400461A EA 200400461 A1 EA200400461 A1 EA 200400461A1
Authority
EA
Eurasian Patent Office
Prior art keywords
treatment
extracts
cimicifuga
plants
family
Prior art date
Application number
EA200400461A
Other languages
English (en)
Other versions
EA006164B1 (ru
Inventor
Вольфганг Вутке
Хубертус Ярри
Волкер Кристоффель
Барбара Шпенглер
Original Assignee
Бионорика Аг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Бионорика Аг filed Critical Бионорика Аг
Publication of EA200400461A1 publication Critical patent/EA200400461A1/ru
Publication of EA006164B1 publication Critical patent/EA006164B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Endocrinology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Reproductive Health (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)

Abstract

Настоящее изобретение относится к применению экстрактов из растений семейства Cimicifuga, в частности из Cimicifuga racemosa, пригодных для получения готового к употреблению медикамента для селективного лечения и/или профилактики нарушений мочеполового тракта, связанных с половыми гормонами. Экстракты согласно изобретению пригодны также для лечения и/или профилактики постменопаузальных инфекций мочевого пузыря. Кроме того, они показаны для лечения доброкачественных и злокачественных гиперплазий простаты.Отчет о международном поиске был опубликован 2003.10.09.
EA200400461A 2001-09-19 2002-09-16 Применение экстрактов из растений семейства cimicifuga в качестве органселективных медикаментов для лечения нарушений мочеполового тракта, связанных с половыми гормонами EA006164B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10146159A DE10146159A1 (de) 2001-09-19 2001-09-19 Verwendung von Extrakten aus Cimicifuga-Arten als organselektives Arzneimittel zur Behandlung von sexualhormonabhängigen Erkrankungen des Urogenitaltraktes
PCT/EP2002/010383 WO2003024465A2 (de) 2001-09-19 2002-09-16 Verwendung von extrakten aus cimicifuga-arten als organselektives arzneimittel

Publications (2)

Publication Number Publication Date
EA200400461A1 true EA200400461A1 (ru) 2004-08-26
EA006164B1 EA006164B1 (ru) 2005-10-27

Family

ID=7699541

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200400461A EA006164B1 (ru) 2001-09-19 2002-09-16 Применение экстрактов из растений семейства cimicifuga в качестве органселективных медикаментов для лечения нарушений мочеполового тракта, связанных с половыми гормонами

Country Status (16)

Country Link
US (3) US7413754B2 (ru)
EP (1) EP1427430B1 (ru)
JP (1) JP2005503404A (ru)
KR (1) KR20040041619A (ru)
AT (1) ATE293985T1 (ru)
AU (1) AU2002362365A1 (ru)
BR (1) BR0212598A (ru)
DE (2) DE10146159A1 (ru)
DK (1) DK1427430T3 (ru)
EA (1) EA006164B1 (ru)
ES (1) ES2238631T3 (ru)
MX (1) MXPA04002592A (ru)
PL (1) PL206937B1 (ru)
PT (1) PT1427430E (ru)
UA (1) UA78228C2 (ru)
WO (1) WO2003024465A2 (ru)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1745796A1 (de) 2005-07-19 2007-01-24 Bionorica Research GmbH Kombinationspräparat insbesondere zur Therapie des Prostatakarzinoms
DE102007044916A1 (de) 2007-09-19 2009-04-23 Bionorica Ag Kosmetische oder dermatologische Zusammensetzung zur topischen Verwendung
MD4025C2 (ru) * 2009-08-25 2010-10-31 Владимир КАРАУШ Средство для лечения простатита и гиперплазии предстательной железы
KR101303693B1 (ko) 2011-06-30 2013-09-04 한국식품연구원 지방 대사 질환, 폐경기 질환 또는 심혈관질환 개선용 조성물
JP2013010796A (ja) * 2012-10-15 2013-01-17 Kao Corp Ｓ１００ａ８発現調節剤
IT201900000343A1 (it) * 2019-01-10 2020-07-10 Herbal E Antioxidant Derivatives S R L Ed In Forma Abbreviata H&Ad S R L Composizioni per il trattamento della menopausa, osteopenia e osteoporosi, disturbi metabolici e vascolari legati al climaterio

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6330417A (ja) 1986-07-23 1988-02-09 Tsumura Juntendo Inc 抗アレルギ−剤
HU204197B (en) 1986-10-30 1991-12-30 Dr Papay Valeria Tothne Process for producing extract for treating aphta, herpes, wounds in the mouth, acne, comedo and pustule
EP0384798B1 (en) 1989-02-06 1993-08-11 Gen-Ichiro Soma Limulus test-positive plant glycolipid, and method of stimulating the immuno system of an animal
US5716646A (en) 1990-05-01 1998-02-10 Smith; Steven A. Methods and compositions for treating arthritis
US5411733A (en) 1992-04-27 1995-05-02 Hozumi; Toyoharu Antiviral agent containing crude drug
CN1090498A (zh) 1993-02-01 1994-08-10 杨芳林 女用口服避孕中成药及制备方法
JP3294694B2 (ja) 1993-11-15 2002-06-24 一丸ファルコス株式会社 ヒオウギ抽出物を含有する細胞賦活剤とその応用
JP3501832B2 (ja) 1993-11-15 2004-03-02 一丸ファルコス株式会社 ヒオウギ抽出物を含有するテストステロン５α−リダクターゼ阻害剤とその応用
US5569459A (en) 1995-02-15 1996-10-29 Bio-Virus Research Incorporated Pharmaceutical compositions for the management of premenstrual syndrome and alleviation of menopausal disorders
JPH0930977A (ja) 1995-07-20 1997-02-04 Tsuneo Nanba 升麻抽出物を含有する骨疾患治療剤
WO1997009032A1 (fr) 1995-09-07 1997-03-13 L'oreal Utilisation d'un extrait d'une bacterie filamenteuse non photosynthetique et composition le contenant
WO1997009056A1 (fr) 1995-09-07 1997-03-13 L'oreal Extrait d'iridacees et compositions le contenant
US6008208A (en) 1995-10-23 1999-12-28 Osteoscreen, Inc. Compositions and methods for treating bone deficit conditions
SE9503775L (sv) 1995-10-26 1997-04-27 Caravan Mill Ab Tekniskt förfarande för torkning, krossning och malning av mussel- och snäckskal
US5916565A (en) * 1996-03-08 1999-06-29 In Clover, Inc. Product and method for treating joint disorders in vertebrates
CN1159340A (zh) 1996-03-11 1997-09-17 李城林 一种抗癌抑瘤药物的配方及其制作工艺
JPH107580A (ja) 1996-06-15 1998-01-13 Michio Yoshida コラゲナ−ゼ阻害剤
JP3665848B2 (ja) 1996-09-18 2005-06-29 木村 幸代 ヒメヒオウギズイセン球根抽出液の発酵飲料及びその製造方法
CN1057690C (zh) 1996-10-18 2000-10-25 宁振峰 治疗卵巢癌的中成药
DE19652183C1 (de) * 1996-12-14 1998-02-12 Schaper & Bruemmer Gmbh Verwendung eines Extraktes aus Cimicifuga racemosa
US5952374A (en) 1997-09-29 1999-09-14 Protein Technologies International, Inc. Method for inhibiting the development of Alzheimer's disease and related dementias- and for preserving cognitive function
US6039290A (en) 1998-03-16 2000-03-21 Honeywell Inc. Robust singularity avoidance in satellite attitude control
DE19812204A1 (de) * 1998-03-19 1999-11-04 Plantamed Arzneimittel Gmbh Verwendung von Extrakten aus Cimicifuga racemosa und Belamcanda sinensis als estrogenartiges organselektives Arzneimittel ohne uterotrope Wirkung
US20050037100A1 (en) * 1998-03-19 2005-02-17 Bionorica Ag Utilization of extracts from iris plants, cimicifuga racemose and tectorigenin as an estrogen-like organ-selective medicament without uterotropic
US6242012B1 (en) 1999-10-19 2001-06-05 Thomas Newmark Herbal composition for promoting hormonal balance in women and methods of using same
US20010025059A1 (en) * 2000-01-10 2001-09-27 Kastke Floyd A. Composition and method for treating non-bacterial prostatitis
WO2001074345A2 (en) 2000-03-31 2001-10-11 Jonathan Ingram Isoflavones for treatment of obesity
JP2002043945A (ja) 2000-07-19 2002-02-08 Sony Corp ディジタル信号符号化装置及び方法、ディジタル信号復号装置及び方法、並びにディジタル信号伝送システム
US6326366B1 (en) 2000-08-22 2001-12-04 Protein Technologies International Hormone replacement therapy
DE10054641A1 (de) 2000-11-03 2002-05-16 Schaper & Bruemmer Gmbh Verwendung einer Zubereitung von Cimicifuga racemosa
US20020172732A1 (en) 2001-03-21 2002-11-21 Wies Ter Laak Composition comprising cocoa

Also Published As

Publication number Publication date
DE10146159A1 (de) 2003-04-10
MXPA04002592A (es) 2005-08-26
WO2003024465A3 (de) 2003-10-09
ES2238631T3 (es) 2005-09-01
WO2003024465A2 (de) 2003-03-27
US20120071501A1 (en) 2012-03-22
PT1427430E (pt) 2005-08-31
US20080300230A1 (en) 2008-12-04
DE50202941D1 (de) 2005-06-02
US7413754B2 (en) 2008-08-19
EA006164B1 (ru) 2005-10-27
DK1427430T3 (da) 2005-05-30
US20050019437A1 (en) 2005-01-27
UA78228C2 (en) 2007-03-15
PL370370A1 (en) 2005-05-16
AU2002362365A1 (en) 2003-04-01
EP1427430A2 (de) 2004-06-16
PL206937B1 (pl) 2010-10-29
ATE293985T1 (de) 2005-05-15
BR0212598A (pt) 2004-10-13
KR20040041619A (ko) 2004-05-17
EP1427430B1 (de) 2005-04-27
JP2005503404A (ja) 2005-02-03

Similar Documents

Publication Publication Date Title
HK1096392A1 (en) Substituted heterocycles
DK1893196T3 (da) Diarylhydantoin-forbindelse
EA200701448A1 (ru) Специфически связывающаяся с крипто-антигеном человека молекула (варианты), композиция на ее основе (варианты), способ получения молекулы, способ лечения посредством молекулы (варианты) и способ ингибирования крипто-экспрессии в клетке больного
NO20052760D0 (no) Fremgangsmate for behandling av kreft og beslektede fremgangsmater.
IN2015DN00502A (ru)
NO20053855D0 (no) 1-fenylalkankarboksylsyrederivater til behandling av neurodegenerative sykdommer.
NO20055307D0 (no) Substituerte isokromanforbindelser for behandling av metabolske forstyrrelser, kreft og andre sykdommer
AR054233A1 (es) Composiciones de anticuerpos igg2
HN2001000244A (es) Inhibidores de espiropirimidin - 2, 4, 6 - triona metaloproteinasas.
WO2005033102A3 (en) Thiophene-based compounds exhibiting atp-utilizing enzyme inhibitory activity, and compositions, and uses thereof
MXPA04003796A (es) Tioacetamidas sustituidas.
WO2002040702A3 (en) Methods for the treatment of cancer and other diseases and methods of developing the same
WO2007016338A3 (en) Use of chk2 kinase inhibitors for cancer treatment
DE60324431D1 (de) Derivate des 3-hydroxy-4-(cyclyl-alkylaminoalkyl)-5-phenyl-1h-pyrazols als antagonisten des gonadotropin freisetzenden hormons (gnrh) zur anwendung in de behandlung von geschlechtshormonellen erkrankungen, wie prostata- oder gebahrmutterkrebs
EA200400461A1 (ru) Применение экстрактов из растений семейства cimicifuga в качестве медикамента для лечения нарушений мочеполового тракта, связанных с половыми гормонами
GB2443588A (en) A pharmaceutcal composition useful for the treatment of prostate cancer
BRPI0412694A (pt) compostos
NO20054723L (no) Behandling av proliferative sykdommer med epofilonderivater og straling
NO20030985L (no) Behandling av betennelsestilstander
NO20072048L (no) Anvendelse av IL-17F for behandling og/eller forebygging av neurologiske sykdommer.
TNSN06147A1 (en) Use of cathepsin k inhibitors for treating of severe bone loss diseases
WO2003022294A3 (de) Extrakt erhältlich aus artemisia abrotanum l. (eberraute)
SE0203093D0 (en) New use
TW200733969A (en) Extract of gentianae macrophyllae radix for the treatment of dermatological diseases
UA33229A (ru) Способ деривации мочи после цистэктомии

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU